Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 18 | 2023 | 1171 | 1.830 |
Why?
|
| Heart Failure | 18 | 2022 | 2516 | 1.420 |
Why?
|
| Hypertension, Pulmonary | 4 | 2020 | 462 | 0.840 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2023 | 192 | 0.770 |
Why?
|
| Myocarditis | 1 | 2022 | 190 | 0.730 |
Why?
|
| Blood Pressure Monitors | 1 | 2018 | 4 | 0.670 |
Why?
|
| Transducers, Pressure | 1 | 2018 | 18 | 0.660 |
Why?
|
| Mineralocorticoid Receptor Antagonists | 1 | 2018 | 30 | 0.660 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2021 | 435 | 0.650 |
Why?
|
| Vascular Resistance | 1 | 2018 | 200 | 0.610 |
Why?
|
| Heart, Artificial | 1 | 2018 | 77 | 0.610 |
Why?
|
| Stroke Volume | 2 | 2022 | 577 | 0.580 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2017 | 473 | 0.570 |
Why?
|
| Drug Overdose | 1 | 2017 | 81 | 0.560 |
Why?
|
| Heart Transplantation | 3 | 2022 | 908 | 0.550 |
Why?
|
| Ventricular Remodeling | 1 | 2013 | 248 | 0.410 |
Why?
|
| Electrocardiography | 1 | 2017 | 1145 | 0.390 |
Why?
|
| Pulmonary Artery | 3 | 2020 | 499 | 0.350 |
Why?
|
| Homocysteine | 1 | 2005 | 138 | 0.260 |
Why?
|
| Thrombosis | 2 | 2022 | 781 | 0.250 |
Why?
|
| Kidney Failure, Chronic | 2 | 2018 | 960 | 0.240 |
Why?
|
| Renal Dialysis | 3 | 2022 | 945 | 0.220 |
Why?
|
| Renal Replacement Therapy | 2 | 2021 | 135 | 0.210 |
Why?
|
| Hypothermia | 1 | 2021 | 59 | 0.200 |
Why?
|
| Hyponatremia | 1 | 2022 | 82 | 0.190 |
Why?
|
| Familial Primary Pulmonary Hypertension | 1 | 2020 | 21 | 0.190 |
Why?
|
| Acute Kidney Injury | 2 | 2019 | 739 | 0.190 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2021 | 89 | 0.180 |
Why?
|
| Hypothermia, Induced | 1 | 2021 | 170 | 0.180 |
Why?
|
| Humans | 30 | 2023 | 261506 | 0.180 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2023 | 343 | 0.180 |
Why?
|
| Rivaroxaban | 1 | 2020 | 59 | 0.180 |
Why?
|
| Plasmapheresis | 1 | 2019 | 61 | 0.180 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2023 | 261 | 0.180 |
Why?
|
| Factor Xa Inhibitors | 1 | 2020 | 70 | 0.180 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2021 | 318 | 0.160 |
Why?
|
| Renal Insufficiency | 1 | 2021 | 321 | 0.160 |
Why?
|
| Antihypertensive Agents | 1 | 2020 | 395 | 0.150 |
Why?
|
| Pyridones | 1 | 2020 | 348 | 0.150 |
Why?
|
| Heparin | 1 | 2019 | 360 | 0.150 |
Why?
|
| Angiotensin Receptor Antagonists | 2 | 2019 | 151 | 0.150 |
Why?
|
| Peptide Fragments | 1 | 2023 | 1271 | 0.150 |
Why?
|
| Hospitals, Urban | 1 | 2017 | 87 | 0.150 |
Why?
|
| Retrospective Studies | 15 | 2023 | 37905 | 0.140 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2022 | 563 | 0.140 |
Why?
|
| Prostheses and Implants | 1 | 2018 | 295 | 0.140 |
Why?
|
| Mortality | 1 | 2018 | 343 | 0.140 |
Why?
|
| Ventricular Function, Left | 2 | 2022 | 603 | 0.130 |
Why?
|
| Reoperation | 1 | 2020 | 1382 | 0.130 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2021 | 581 | 0.130 |
Why?
|
| Thrombocytopenia | 1 | 2019 | 846 | 0.120 |
Why?
|
| Hemodynamics | 1 | 2018 | 935 | 0.120 |
Why?
|
| Exercise Test | 1 | 2015 | 312 | 0.120 |
Why?
|
| Oxygen Consumption | 1 | 2015 | 401 | 0.120 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2013 | 36 | 0.120 |
Why?
|
| Hospitalization | 2 | 2019 | 2083 | 0.110 |
Why?
|
| Middle Aged | 14 | 2023 | 86204 | 0.110 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2012 | 44 | 0.110 |
Why?
|
| Cardiovascular Diseases | 1 | 2005 | 2195 | 0.110 |
Why?
|
| Time Factors | 4 | 2022 | 12926 | 0.100 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2013 | 257 | 0.100 |
Why?
|
| Male | 14 | 2021 | 123000 | 0.100 |
Why?
|
| Risk Factors | 5 | 2022 | 17523 | 0.100 |
Why?
|
| Acute Disease | 1 | 2017 | 2422 | 0.100 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2013 | 323 | 0.100 |
Why?
|
| Pyrazoles | 1 | 2020 | 1471 | 0.100 |
Why?
|
| Angioplasty, Balloon | 1 | 2012 | 183 | 0.100 |
Why?
|
| Treatment Outcome | 9 | 2022 | 32848 | 0.100 |
Why?
|
| Heart Defects, Congenital | 1 | 2022 | 1697 | 0.100 |
Why?
|
| Patient Selection | 1 | 2018 | 2055 | 0.090 |
Why?
|
| Hospital Mortality | 3 | 2023 | 1274 | 0.090 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2020 | 1237 | 0.090 |
Why?
|
| Recovery of Function | 1 | 2013 | 703 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 4320 | 0.090 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 14889 | 0.080 |
Why?
|
| Adult | 8 | 2022 | 77950 | 0.080 |
Why?
|
| Incidence | 4 | 2019 | 5673 | 0.070 |
Why?
|
| Female | 13 | 2021 | 141928 | 0.070 |
Why?
|
| Heart | 1 | 2013 | 1223 | 0.070 |
Why?
|
| Atrial Fibrillation | 1 | 2014 | 719 | 0.070 |
Why?
|
| Postoperative Complications | 2 | 2020 | 5542 | 0.070 |
Why?
|
| Equipment Design | 2 | 2021 | 1204 | 0.070 |
Why?
|
| Prognosis | 3 | 2021 | 21713 | 0.070 |
Why?
|
| Young Adult | 3 | 2020 | 21445 | 0.070 |
Why?
|
| Vitamin B 12 | 1 | 2005 | 73 | 0.070 |
Why?
|
| Anticoagulants | 2 | 2022 | 787 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 980 | 0.060 |
Why?
|
| Folic Acid | 1 | 2005 | 349 | 0.060 |
Why?
|
| Registries | 2 | 2021 | 2170 | 0.050 |
Why?
|
| Aged | 7 | 2020 | 70117 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2017 | 12873 | 0.050 |
Why?
|
| Coma | 1 | 2021 | 61 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 543 | 0.050 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2020 | 62 | 0.050 |
Why?
|
| Tracheostomy | 1 | 2023 | 243 | 0.050 |
Why?
|
| United States | 4 | 2019 | 15433 | 0.050 |
Why?
|
| Diastole | 1 | 2020 | 187 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2013 | 2947 | 0.050 |
Why?
|
| Survival Rate | 3 | 2019 | 12221 | 0.040 |
Why?
|
| Neprilysin | 1 | 2019 | 66 | 0.040 |
Why?
|
| Thromboembolism | 1 | 2020 | 155 | 0.040 |
Why?
|
| Shock, Cardiogenic | 1 | 2021 | 228 | 0.040 |
Why?
|
| Warfarin | 1 | 2020 | 152 | 0.040 |
Why?
|
| Hospital Costs | 1 | 2019 | 228 | 0.040 |
Why?
|
| Equipment Failure | 1 | 2018 | 191 | 0.040 |
Why?
|
| Survivors | 1 | 2021 | 1031 | 0.030 |
Why?
|
| Prosthesis Implantation | 1 | 2018 | 263 | 0.030 |
Why?
|
| Echocardiography | 1 | 2020 | 1182 | 0.030 |
Why?
|
| Quality of Life | 2 | 2021 | 4532 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2019 | 1819 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 2594 | 0.030 |
Why?
|
| Medicare | 1 | 2018 | 860 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 29902 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2017 | 846 | 0.030 |
Why?
|
| Ventricular Pressure | 1 | 2012 | 46 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2018 | 755 | 0.030 |
Why?
|
| Pulmonary Edema | 1 | 2012 | 80 | 0.030 |
Why?
|
| Stroke | 1 | 2020 | 1144 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2022 | 9180 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 3719 | 0.020 |
Why?
|
| Adolescent | 2 | 2020 | 31252 | 0.020 |
Why?
|
| Radiography | 1 | 2012 | 1904 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6207 | 0.020 |
Why?
|
| Child | 1 | 2022 | 29154 | 0.010 |
Why?
|